4.3 Article

DNA extraction from primary liquid blood cultures for bloodstream infection diagnosis using whole genome sequencing

期刊

JOURNAL OF MEDICAL MICROBIOLOGY
卷 67, 期 3, 页码 347-357

出版社

MICROBIOLOGY SOC
DOI: 10.1099/jmm.0.000664

关键词

bloodstream infection; sepsis; bacteraemia; whole genome sequencing

资金

  1. Wellcome Trust [WT098615/Z/12/Z]
  2. Department of Health [T5-358]
  3. NIHR Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford with Public Health England (PHE) [HPRU-2012-10 041]
  4. National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust
  5. University of Oxford
  6. Wellcome Trust/Royal Society Sir Henry Dale Fellowship [102541/Z/13/Z]
  7. Wellcome Trust PhD studentship
  8. Wellcome Trust [102541/Z/13/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

Purpose. Speed of bloodstream infection diagnosis is vital to reduce morbidity and mortality. Whole genome sequencing (WGS) performed directly from liquid blood culture could provide single-assay species and antibiotic susceptibility prediction; however, high inhibitor and human cell/DNA concentrations limit pathogen recovery. We develop a method for the preparation of bacterial DNA for WGS-based diagnostics direct from liquid blood culture. Methodology. We evaluate three commercial DNA extraction kits: BiOstic Bacteraemia, Amplex Hyplex and MolYsis Plus. Differential centrifugation, filtration, selective lysis and solid-phase reversible immobilization bead clean-up are tested to improve human cells/DNA and inhibitor removal. Using WGS (Illumina/MinION), we assess human DNA removal, pathogen recovery, and predict species and antibiotic susceptibility inpositive blood cultures of 44 Gram-negative and 54 Staphylococcus species. Results/Key findings. BiOstic kit extractions yield the greatest mean DNA concentration, 94-301 ng mu l(-1), versus 0-2.5 ng mu l(-1) using Amplex and MolYsis kits. However, we note higher levels of inhibition (260/280 ratio 0.9-2.1) and human DNA (0.0-4.4 x 10(6) copies) in BiOstic extracts. Differential centrifugation (2000 g, 1 min) prior to BiOstic extraction reduces human DNA by 63-89% with selective lysis minimizing by a further 62 %. Post-extraction bead clean-up lowers inhibition. Overall, 67% of sequenced samples (Illumina MiSeq) contain < 10% human DNA, with > 93% concordance between WGS-based species and susceptibility predictions and clinical diagnosis. If > 60% of sequencing reads are human (7/98 samples) susceptibility prediction becomes compromised. Novel MinION-based WGS (n=9) currently gives rapid species identification but not susceptibility prediction. Conclusion. Our method for DNA preparation allows WGS-based diagnosis direct from blood culture bottles, providing species and antibiotic susceptibility prediction in a single assay.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据